Skip to main content
Download PDF

Role of the chemokine receptor CCR5-dependent host defense system in Neospora caninum infections

Parasites & Vectors volume 8, Article number: 5 (2015) Cite this article

Abstract

Background

Neospora caninum, a Toxoplasma gondii-like obligate intracellular parasite, causes abortion in cattle and neurological signs in canines. To understand neosporosis better, studies on host cell migration and host immune responses during the early phase of infection are important. Although the C-C chemokine receptor 5 (CCR5) plays a crucial role in immune cell migration, the role played by it in protective immunity against N. caninum is poorly understood.

Methods

CCR5−/− mice were used to investigate their sensitivity levels to N. caninum infection and their ability to activate immune cells against this parasite.

Results

Increased mortality and neurological impairment were observed in the N. caninum-infected CCR5−/− mice. In comparison with wild-type mice, CCR5−/− mice experienced poor migration of dendritic cells and natural killer T cells to the site of infection. Dendritic cells in an in vitro culture from CCR5−/− mice could not be activated upon infection with N. caninum. Furthermore, higher levels of IFN-γ and CCL5 expression, which are associated with brain tissue damage, were observed in the brain tissue of CCR5−/− mice during the acute phase of the infection, while there was no significant difference in the parasite load between the wild-type and CCR5−/− animals. Additionally, a primary microglia culture from CCR5−/− mice showed lower levels of IL-6 and IL-12 production against N. caninum parasites.

Conclusions

Our findings show that migration and activation of immune cells via CCR5 is required for controlling N. caninum parasites during the early phase of the infection.

Background

Neospora caninum is an obligate intracellular apicomplexan parasite. This parasite is a cause of neosporosis, which leads to abortion, neonatal mortality and congenital infection in cattle, and neuromuscular signs in canines [1]. Calves infected vertically also have neurologic signs including hind limbs that are flexed and hyperextended, and loss of conscious proprioception [2]. The ability of a host to survive an infection with N. caninum is IFN-γ-dependent [3]. IFN-γ is a known major mediator of resistance against Toxoplasma gondii, a parasite closely related to N. caninum [4]. IL-12 stimulates production of IFN-γ from natural killer (NK) cells, CD4+ cells and CD8+ cells [5]. In one study, N. caninum infection induced IL-12 synthesis by dendritic cells and macrophages, suggesting that IFN-γ-secretion by T lymphocytes in combination with IL-12 production occurred following interactions between T cells and antigen-presenting cells [6].

Chemokines are a large family of chemotactic proteins, which regulate leukocyte activation and recruitment to sites of inflammation via interaction with a family of chemokine receptors [7]. Cystein–cystein chemokine receptor 5 (CCR5) and its ligands, such as macrophage inflammatory protein-1 alpha (MIP-1α) and beta (MIP-1β), play a role in IFN-γ generation during the early phase of infection with Leishmania donovani [8]. CCR5-deficiency in mice decreases susceptibility to experimental cerebral malaria infection [9], suggesting that interactions between host CCR5 and malaria parasites are important for parasite control of the infection. During T. gondii infection, T. gondii cyclophilin 18 (TgCyp18) was found to induce IL-12 production through binding to CCR5 in a CCR5-dependent manner [10,11]. In the case of N. caninum, excreted and secreted antigens triggered monocytic cell migration to the site of infection in a CCR5-dependent manner [12]. Moreover, N. caninum cyclophilin caused CCR5-dependent migration of murine and bovine cells [13]. Thus, CCR5 regulates the type of immune cell migration and cytokine production required for host control of parasites in T. gondii and N. caninum infections. However, the role played by CCR5 in protective immunity against N. caninum has not been clarified as yet. In this study, we investigated the sensitivity levels and degree of neurological impairment of CCR5−/− mice infected (intraperitoneally) with N. caninum to obtain better understanding of the role of CCR5-dependent host immunity.

Methods

Ethics statement

This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the Ministry of Education, Culture, Sports, Science and Technology, Japan. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Obihiro University of Agriculture and Veterinary Medicine (Permit number 25–59, 24–15, 23–61). All surgery for sampling of cardiac puncture blood, tissues, bones and ascites was performed under isoflurane anesthesia, and all efforts were made to minimize animal suffering.

Mice

C57BL/6 J mice, 5–8 weeks of age, were obtained from Clea Japan (Tokyo, Japan). CCR5 knockout (CCR5−/−) mice (B6.129P2-Ccr5tmlKuz/J, Stock No. 005427) were purchased from the Jackson Laboratory (Bar Harbor, Maine, USA). The mice were housed under specific pathogen-free conditions in the animal facility of the National Research Center for Protozoan Diseases at the Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Japan.

Parasites and in vivo infections

N. caninum (Nc-1 isolate) tachyzoites and its recombinants expressing the GFP were maintained in monkey kidney adherent epithelial cells (Vero cells) cultured in Eagle’s minimum essential medium (EMEM, Sigma, St Louis, USA) supplemented with 8% heat-inactivated fetal bovine serum (FBS). To purify tachyzoites, parasites and host cell debris were washed with PBS, after which the final pellet was resuspended in PBS and passed through a 27-gause needle and a 5.0-μm-pore-size filter (Millipore, Bedford, MA, USA). Male mice were experimentally infected by the i.p. route with 1 × 106 tachyzoites per mouse. All mice were monitored for survival and scored on a daily basis for the neurological signs characteristic of neosporosis, including torticollis and circling motion. Clinical score-assessed neurological signs such as torticollis and circling motion scored 1 point each. Dead mice showing neurological signs were assigned a maximal score of 2. The scores were assessed using a modified set of criteria adapted by Reichel and Ellis [14].

Quantitation of parasite burden

For DNA preparation, brain, lung, liver, and spleen were collected, frozen at −80°C, and resuspended in ten weight equivalent volumes of extraction buffer (0.1 M Tris–HCl pH 9.0, 1% SDS, 0.1 M NaCl, and 1 mM EDTA) and 100 μg/ml of Proteinase K at 50°C. DNA was purified by phenol–chloroform extraction and ethanol precipitation. For each tissue, the DNA concentration was adjusted to 50 ng per μl and 1 μl was used as template DNA. Parasite DNA was quantified as described previously [15]. Oligonucleotide primers were designed to amplify a 76-bp DNA fragment of the N. caninum Nc5 sequence (GenBank accession no. X84238). The N. caninum Nc5 forward primer spans nucleotides 248 to 257 (5’-ACT GGA GGC ACG CTG AAC AC-3’) and the N. caninum Nc 5 reverse primer spans nucleotides 303 to 323 (5’-AAC AAT GCT TCG CAA GAG GAA-3’). PCRs (25-μl total volume) contained 1 × SYBR Green PCR Buffer, 2 mM MgCl2, a 200 μM concentration each of dATP, dCTP, and dGTP, 400 μM dUTP, 0.625 U of AmpliTaq Gold DNA polymerase, and 0.25 U of AmpErase UNG (urasil-N-glycosilase) (all of which are included in the Power SYBR Green PCR Master Mix, PE Applied Biosystems, Foster City, CA, USA); additionally, 20 pmol of each primer (Amersham Pharmacia Biotech, Inc., Piscataway, NJ) and 1 μl of template DNA were added. Amplification was performed by a standard protocol recommended by the manufacturer (2 min at 50°C, 10 min at 95°C, 40 cycles at 95°C for 15 s, and 60°C for 1 min). Amplification, data acquisition, and data analysis were performed by the ABI 7700 Prism Sequence Detector (Applied Biosystems, Foster City, CA, USA), and the cycle threshold (Ct) values calculated were exported to Microsoft Excel for analysis. A standard curve was established from N. caninum DNA extracted from 1 × 105 parasites using 1 μl samples of serial dilutions ranging from 10,000 to 0.01 parasites. Parasite numbers were calculated by interpolation of the standard curve, with the Ct values plotted against a known concentration of parasites. To confirm the specificity of the PCRs, DNA from the brain of an uninfected mouse and from purified N. caninum tachyzoites were used as the negative and positive controls, respectively. The limit of detection was 0.1 parasites in 50 ng of tissue DNA.

Real-time RT-PCR analysis

Total RNA was prepared from brain and liver samples from the CCR5−/− (N = 10) and C57BL/6 mice (N = 10) using TriReagent™ (Sigma, USA) according to the manufacturer’s instructions. First-strand cDNA synthesis used an oligo (dt) primer and RT-superscript II (Invitrogen, Carlsbad, CA, USA) reverse transcriptase. PCR was performed as described above, using Power SYBR Green PCR Master Mix and an ABI 7700 Prism Sequence Detector instrument. The relative mRNA amounts were calculated using the comparative CT method (User Bulletin no. 2, Perkin-Elmer). The primer sequences (sense and antisense sequences) designed by Primer Express Software (Applied Biosystems, Foster City, CA, USA) were as follows: β-actin sense primer 5’-GCT CTG GCT CCT AGC ACC AT-3’, β-actin antisense primer 5’-GCC ACC GAT CCA CAC AGA GT-3’, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) sense primer 5’-TGT GTC CGT CGT GGA TCT GA -3’, GAPDH antisense primer 5’- CCT GCT TCA CCA CCT TGT TGA T-3’, mouse IFN-γ sense primer 5’-GCC ATC AGC AAC AAC ATA AGC GTC-3’, mouse IFN-γ antisense primer 5’-CCA CTC GGA TGA GCT CAT TGA ATG-3’, human CCL5 sense primer 5’-GCT TGC AAA CAC CTG ATG TCC-3’, human CCL5 antisense primer 5’-CCC TTC TCG GAG AGC TTT TGT-3’, TNF-α sense primer 5’-GGC AGG TCT ACT TTG GAG TCA TTG C-3’, TNF-α antisense primer 5’-ACA TTC GAG GCT CCA GTG AA-3’. Gene-specific expression was normalized against β-actin and GAPDH housekeeping gene expression. The optimal reference gene was selected based on the Cotton EST database (http://www.leonxie.com).

Pathological analysis

After fixation, the coronally cut liver, spleen, lung and brain tissue samples were embedded in paraffin wax, sectioned to 4 μm, and then stained with hematoxylin and eosin. To estimate the severity of the histopathological lesions in the brain, they were scored using the following scheme: 0, no lesion; 1, minimal lesions limited to localized perivascular cuffs or slight mononuclear cell infiltration in the meninges; 2, mild lesions, including perivascular cuffs, meningitis and local glial cell infiltration; 3, moderate lesions, including perivascular cuff, meningitis, glial cell infiltration, focal necrosis and rarefaction of the neuropil with occasional macrophage infiltration; 4, severe lesions, including perivascular cuffs, meningitis, glial cell infiltration, rarefaction of the neuropil and extensive necrosis. The scores for each lesion were added for each section, and the total pathological score for each section was used in the data analysis. We scored one section that including some pieces of brain tissue cut coronally in each mouse.

Preparation of peritoneal cells

Peritoneal exudate cells from the mice were harvested by lavage with 5 ml of ice-cold PBS. The cells were filtered through a 40-μm cell strainer to remove cell aggregates and small pieces of debris. The cells were centrifuged at 1,000 × g for 5 min, suspended in PBS and used for flow cytometric analysis.

Flow cytometric analysis and antibodies

Cells were prepared for fluorescence activated cell sorting analysis as described below. Following removal of the culture medium, the cells were washed with PBS and resuspended in cold PBS containing 0.5% bovine serum albumin. The cells were treated with FcBlock™ to avoid the non-specific adherence of mAbs to Fc receptors, and then incubated with their respective monoclonal antibodies (Additional file 1: Table S1) for 15 min at 4°C. The stained cells (monocyte/macrophage; CD11b+ CD11c−, dendritic cell; CD11b− CD11c+, neutrophil; Gr-1+ MHC class II−, natural killer (NK) cell; CD3− NK1.1+, NKT cells; CD3+ NK1.1+, T cell; CD3+) were washed with cold PBS, fixed with 0.5% paraformaldehyde in PBS, and examined with an EPICS XL flow cytometer (Beckman Coulter, Hialeah, USA). N. caninum-infected cells were GFP+ by flow cytometry. The absolute number of each cell marker was calculated as follows: the absolute cell number = the total host cell number × (the percentage of marker+ cells/100) × (the percentage of gated cell by the flow cytometry/100).

Preparation of peritoneal macrophages for in vitro studies

CCR5−/− and C57BL/6 mice were injected i.p. with 1 ml of 4.05% thioglycolate. Four days after these injections, peritoneal exudate cells were harvested from the mice by lavage with 5 ml of ice-cold PBS and depleted of red blood cells with 0.83% NH4Cl and 0.01 M Tri-HCl, pH 7.2. Cells were centrifuged at 1,000 × g for 10 min and suspended in DMEM (Sigma) supplemented with 10% FBS. The macrophage suspension was then added to a 12-well plate at 1 × 106 cells/well. After 24 h incubation, the macrophages (1 × 106 cells) were infected with 2 × 105  N. caninum tachyzoites and incubated for 24 h for in vitro analysis. Cells were found to be 97% macrophages, as judged by positive staining for CD11b.

Preparation of bone marrow-derived dendritic cells (BMDCs)

BMDCs were prepared by a reported method [16] with some modifications. After removing all muscle tissues from the mouse femurs and tibias, the bones were placed into a fresh dish with RPMI 1640 medium (Sigma). Both ends of each bone were cut with scissors and the bone marrow cells were flushed out with a syringe and a 25-gause needle using RPMI 1640 medium. Following lysis and red blood cell removal, the cells were resuspended in RPMI 1640 supplemented with 10% FBS and 10 ng/ml of murine recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) (R&D Systems, Minneapolis, MN, USA) and cultured in a 24-well plate at 5 × 105 cells/well at 37°C. The cells were cultured for 7 days and the supernatants were gently removed and replaced with fresh media every 48 h. On day 8 of culturing, mature and loosely attached BMDCs (5 × 105 cells) were infected with 2 × 105 tachyzoites and incubated for 24 h for in vitro analysis.

Preparation of microglia cultures

Murine microglia were cultured from the brain cortices of neonatal mice (age, E17-18), following the procedure previously described [17], with some modifications. Pups were decapitated and their brains were removed, the cortices were dissected, and the meninges were removed. Tissues were mechanically dissociated into a single-cell suspension in DMEM containing 0.25% trypsin and 0.01% DNase at 37°C for 10 min. After washing, the cells were resuspended in DMEM/F-12 (Gibco, Carlsbad, CA, USA) supplemented with penicillin–streptomycin (0.5 mg/ml), 10% FBS, and 10 ng/ml of GM-CSF, and then plated into 75-cm2 flasks at 4 × 106 cells. The cultures were incubated at 37°C. Cell culture medium was changed thereafter every three days. After 10 to 11 days, microglial cells were detached from the astrocyte monolayer by pipetting. The supernatants were collected and centrifuged, and the cells were reseeded on a 24-well plate at 2 × 105 cells/well. Microglial cells were allowed to grow for an additional 16 h before the experiments were started. The microglial cells (2 × 105 cells) were infected with 2 × 105 tachyzoites and incubated for 24 h for in vitro analysis. Cells were found to be 95% microglia as judged by positive staining for CD11b.

Cytokine enzyme-linked immunosorbent assay (ELISA)

IL-6 and IL-12 p40 levels in the culture supernatant of peritoneal macrophages, BMDCs and microglia and in the sera and ascites of mice were measured by an OptEIA™ Mouse IL-6 or IL-12 (p40) ELISA Set (BD Bioscience, San Jose, CA, USA), respectively, according to the manufacturer’s instructions.

Statistical analysis

The various assay conditions used herein were evaluated with a Student’s t-test or ANOVA test followed by Tukey’s multiple comparisons procedure. The statistical significance of differences in mouse survival was analyzed with a Kaplan–Meier nonparametric model and the curves were compared using the log-rank test.

Results

Survival rates and clinical scores of CCR5-deficient mice infected with N. caninum

CCR5−/− mice showed significantly higher mortality rates than C57BL/6 mice (Figure 1A). More than 60% of the C57BL/6 mice survived whereas all CCR5−/− mice succumbed to the infection. CCR5−/− mice also showed higher weight loss compared with C57BL/6 mice after the infection. Moreover, higher clinical scores assessing the severity of the neurological signs (e.g., torticollis and circling motion), which occurred at an earlier stage of the infection, were observed in the CCR5−/− mice than in the C57BL/6 mice (Figure 1B).

Figure 1
figure 1

Survival rate and clinical score of mice following lethal challenge with N. caninum . (A) Survival rates of N. caninum-infected CCR5−/− and C57BL/6 mice (wild-type, WT). Data were analyzed by a log-rank test. *** P < 0.001. (B) Clinical scores represent the mean total values for all mice used in this study. Data were obtained from two independent experiments performed together (CCR5−/− mice, N = 5 + 6; C57BL/6 mice, N = 6 + 7).

Full size image

Parasite tissue burden

Next, the number of parasites in brain, lung, liver and spleen tissues of mice at 5 day post-infection were measured by quantitative real-time PCR (Figure 2). As a result, no significant difference was found between tissue samples of the same organs from the two groups.

Figure 2
figure 2

Parasite burden in tissues. The values are the number of parasites in 50 ng of tissue DNA. The number of parasites per individual (symbols) and mean levels (horizontal lines) are indicated (N = 9). Data were obtained from two independent experiments performed together. No significant difference was observed between the two groups by a student’s t-test.

Full size image

Migration of peritoneal cells to the site of infection

The number of CD11b+ cells (monocytes and macrophages) that had migrated was not significantly different between the two groups (Figure 3A). In contrast, CD11c+ dendritic cells in the CCR5−/− mice showed less migration than CD11c+ dendritic cells in the C57BL/6 mice at 5 days post-infection (Figure 3B). Similar migration dynamics for neutrophils, NK cells, and T cells were observed between the two groups, at 0, 5 and 10 days post-infection (Figures 3C, D, F). However, the NKT cells showed impaired migration in the CCR5−/− mice at 10 days post-infection (Figure 3E). The flow cytometry results using N. caninum tachyzoites-expressing GFP showed that there was no significant difference in the infection rates and absolute numbers of the infected CD11b+ cells, CD11c+ cells, or CD3+ cells obtained from the peritoneal cells (Table 1).

Figure 3
figure 3

Migration of peritoneal cells to the site of infection. Peritoneal cells (PEC) were obtained from CCR5−/− mice and C57BL/6 mice (wild-type, WT) at 0, 5 and 10 days post-infection (dpi) with 1 × 106  N. caninum tachyzoites (0 dpi, N = 3; 5 dpi, N = 9 from two independent experiments; 10 dpi, N = 5). The cells were subjected to flow cytometry to determine the absolute number of monocytes/macrophages (A), dendritic cells (B), neutrophils (C), NK cells (D), NKT cells (E) and T cells (F). Cell number per individual (symbols) and mean levels (horizontal lines) are indicated. Data were analyzed by a student’s t-test and compared with values taken on the same day post-infection. *P < 0.05.

Full size image
Table 1 Infection rates and number of CD11b + , CD11c + , or CD3 + cells infected with N. caninum -expressing GFP
Full size table

Activation of macrophages and dendritic cells during N. caninum infection

No difference in CD80 activation was observed, whereas there was significantly impaired CD86 activation in CCR5−/− macrophages compared with the wild-type macrophages (Figure 4A). Additionally, in both cases, activation of CD80 and CD86 (costimulatory molecules) was significantly diminished in CCR5−/− BMDCs upon N. caninum infection (Figure 4B). Although N. caninum infection triggered the production of IL-6 and IL-12p40 in the macrophages and BMDCs, there was no significant difference between wild-type and CCR5−/− cells (data not shown).

Figure 4
figure 4

Expression of cell surface markers on peritoneal macrophages and BMDCs. The peritoneal macrophages (A) and BMDCs (B) were obtained from CCR5−/− mice and C57BL/6 mice (wild-type, WT). Each value represents the mean fluorescence intensity (MFI) of the marker ± the standard deviation of three replicate samples. “–” indicates no stimuli and “+” indicates infection with N. caninum tachyzoites (Nc1). Data were analyzed by one-way ANOVA tests followed by Tukey’s multiple comparison. ***P < 0.001. Reproducibility of the data was confirmed by three independent experiments.

Full size image

Measurement of inflammatory markers in liver and brain

At 5 days post-infection, IFN-γ, IL-6, IL-12p40 and nitric oxide (NO) levels were not significantly different in the serum and the ascites fluid between the wild-type and CCR5−/− mice (data not shown). At 5 days post-infection, IFN-γ and CCL5 mRNA levels in the brains of the infected CCR5−/− mice were significantly higher than those of the infected wild-type animals (Figure 5A); however, there was no significant difference in the IFN-γ and TNF-α expression levels in the liver (Figure 5B).

Figure 5
figure 5

Inflammatory marker expression in mouse brain and liver. Brain and liver obtained from infected CCR5−/− mice and C57BL/6 mice (wild-type, WT) at 5 days post-infection were prepared for measurement of their mRNA levels. The mRNA levels in brain (A) and liver (B) were standardized against the β-actin and GAPDH mRNA level values, respectively. The values per individual (symbols) and mean levels (horizontal lines) are indicated. Data were obtained from two independent experiments performed together. The individual with undetectable expression are not indicated. Data were analyzed by a student’s t-test. *P < 0.05.

Full size image

Pathological analysis of infected mice

We performed a pathological analysis of liver, spleen, kidney, heart, lung and brain at 5 days post-infection. In liver, mononuclear cell infiltration was observed in both groups of mice (five mice per group) while some CCR5−/− mice showed focal necrosis (data not shown). However, there were no significant findings in the other organs. Next, pathological change of brain at 8 days post-infection was examined. Two of nine C57BL/6 mice and four of nine CCR5−/− mice died before their brains were collected. While only slight to mild lesions, including perivascular cuffs, were observed in the brains of two C57BL/6 mice (Figure 6A), slight to moderate lesions including glial cell infiltration and meningitis were observed in the brains of the CCR5−/− mice (Figure 6B). Although some mice in the CCR5−/− group had a high pathological score (Figure 6C) and a high parasite load in their brain data not shown, no statistically significant difference was observed between the CCR5−/− and C57BL/6 groups.

Figure 6
figure 6

Pathological analysis of brain tissue. Slight to mild lesions including perivascular cuffs were observed in the C57BL/6 mice (A), and slight to moderate lesions including necrotic focus with glial cell infiltration were observed in the CCR5−/− mice (B). Additionally, the severity of the histopathological lesions was analyzed (C). No significant difference was observed in the pathological score between the two groups (student’s t-test).

Full size image

Microglia activation during N. caninum infection

As shown in Figure 7A, CD86 expression was significantly lower in CCR5−/− microglia with or without infection while no significant difference in activation of MHC class II was observed (data not shown). Moreover, IL-6 and IL-12p40 production levels in CCR5−/− microglia were significantly lower than those in wild-type cells during N. caninum infection (Figure 7B). In contrast, there was no significant difference in IL-6 production between wild-type and CCR5−/− primary astrocytes (data not shown).

Figure 7
figure 7

Expression of cell surface markers and cytokine production in microglia. (A) Each value represents the mean fluorescence intensity (MFI) of the marker ± the standard deviation of four replicate samples. “–” indicates no stimuli and “+” indicates infection with N. caninum tachyzoites (Nc1). (B) IL-6 and IL-12p40 in the culture supernatant were analyzed by cytokine ELISA. Each value represents the mean ± standard deviation of four replicate samples. Data were analyzed by one-way ANOVA tests followed by Tukey’s multiple comparison. **P < 0.01, ***P < 0.001. Reproducibility of the data was confirmed by two independent experiments.

Full size image

Discussion

In the present study, we showed that CCR5−/− mice experienced increased mortality during N. caninum infection compared with C57BL/6 mice. It has been shown that CCR5 is crucially involved in the pathway underlying resistance to T. gondii because of its ability to induce IL-12 production by dendritic cells [10,18]. Additionally, CCR5−/− mice have been shown to display enhanced parasite burden and mortality during T. gondii infection [19]. These results suggest that CCR5 plays a physiological role in immunology and inflammation during parasite infection. Alternatively, antigen-presenting cells may transport intracellular pathogens such as N. caninum and T. gondii away from the sites of primary infection and help them to propagate inside the host [12,20]. However, in the present study, no difference in the parasite load in the organs of CCR5−/− and wild-type mice was seen at 5 and 8 days post-infection with N. caninum. This result suggests that parasite burden does not contribute to death in CCR5−/− mice during N. caninum infection.

It is well-known that rapid recruitment of monocytes/macrophages to the sites of infection has potential to enhance the innate immune responses of the host against pathogens. Our recent results showed that macrophage-depleted mice exhibited increased sensitivity to N. caninum infection [21]. However, migration of monocytes/macrophages to the site of infection was not significantly different between CCR5−/− and wild-type mice. Additionally, CCR5−/− macrophage activation upon infection with N. caninum was similar to that of the wild-type cells, with the exception of CD86 expression levels. Therefore, other factors may play a role in the increased mortality of CCR5−/− mice during infection with N. caninum.

Significant differences were observed in the migration of dendritic cells and NKT cells at 5 and 10 days post-infection, respectively, indicating that these cells migrated to the sites of infection in a CCR5-dependent manner. Our group previously showed that depletion of NKT cells, but not NK cells, increased the parasite burden in mouse brains and inhibited the activation of CD4+ cells, suggesting that NKT cells play a crucial role in protection against the early stage of N. caninum infection [22]. Thus, NKT cells may contribute to CCR5-dependent protective immunity. The main role of dendritic cells is antigen presentation; therefore, impairment of dendritic cell migration and activation suppresses the induction of antigen presentation in the lymph nodes, leading to down-regulation of adaptive immunity [6]. CD80 and CD86 expression levels in the CCR5−/− dendritic cells were significantly lower than those in the wild-type cells. This suggests that CCR5-mediated activation of dendritic cells and NKT cells in response to N. caninum may be partially involved in protective immunity despite the similar parasite burden and infection rates in the tissue or cells between the CCR5−/− and wild-type mice.

Interestingly, brain (but not liver) from the N. caninum-infected CCR5−/− mice showed more severe tissue damage and increased inflammation than the same tissue from the infected wild-type animals, despite no significant difference in the parasite load between the groups. Glial cells such as astrocytes and microglia play an important role in brain homeostasis. Astrocytes support neuronal function by secreting neuropoietic factors such as IL-6 [23]. However, no significant production of IL-6 between wild-type and CCR5−/− primary astrocytes was seen upon infection with N. caninum. Microglia cells are responsible for initial immune defenses in the central nervous system (CNS). In response to tissue injury or pathogen infection, microglia proliferate and secrete pro- and anti-inflammatory cytokines, prostaglandins and free radicals [24]. Microglia appear to be the major effector cells that inhibit T. gondii tachyzoite proliferation in the brain via TNF-α, IL-6 or NO [25,26]. Microglia, which act like macrophages or dendritic cells in the brain, produce the cytokines necessary for recruitment and activation of T cells to control T. gondii infection [27]. In the present study, in comparison with the wild type microglia, CCR5−/− cells showed lower expression levels of CD86 and impaired production of IL-6 and IL-12 p40 against in vitro infection with N. caninum, suggesting that CCR5−/− microglia were unable to trigger neuroprotection or the level of protective immunity required to clear parasites from the brain. Moreover, CCR5 and its ligands are expressed in microglia and neurons, respectively, in response to nerve injury, suggesting that CCR5-mediated neuron-glia signaling protects neurons by suppressing microglia toxicity [28]. Although the ability of IFN-γ to reduce parasite numbers is well-known [27], overproduction of it causes tissue damage [19]. CCL5, one of the ligands for CCR5, is expressed in response to inflammation following T cell recruitment [29]. In the present study, IFN-γ and CCL5 mRNA expression in brain tissue was significantly elevated in the CCR5−/− mice compared with that of the wild-type mice; however, no significant difference was observed in IFN-γ and TNF-α mRNA levels in liver tissue between these groups of mice, indicating that there was more severe damage to the brains of infected CCR5−/− mice. Thus, brain damage caused by microglia dysfunction might result in the earlier onset of neurological signs in CCR5−/− mice after infection with N. caninum.

Neurological signs are a typical feature of neosporosis. In most CNS diseases, CCR5 deletion is deleterious to the host; infectious agents for which this has been shown include Cryptococcus neoformans [30], herpes simplex virus [31,32], and West Nile Virus [33]. In contrast, CCR5-deficiency in mice diminished susceptibility to infection with Plasmodium berghei (ANKA strain) by reducing CD8+ T cell accumulation and T-helper 1 cytokine production in the brain [9]. If, in some cases, CCR5 represents a susceptibility factor for the spread of pathogens in the brain, in others it confers resistance against the development of severe disease. To better understand the physiological role of CCR5, the function of its ligand should be considered. Interestingly, T. gondii possesses a unique molecule for stimulating immune responses and cell migration in the host. TgCyp18 appears to induce IL-12 production by interacting directly with CCR5 [11,18,34]. Moreover, overproduction of TgCyp18 regulates host cell migration and enhances parasite dissemination in a CCR5-independent manner [35]. N. caninum also has a cyclophilin gene. However, N. caninum-derived cyclophilin (NcCyp) appears to contribute to host cell migration in a CCR5-dependent way [13]. Therefore, the complex reactions underlying the development of neosporosis and the involvement of CCR5 and NcCyp in immune and nervous system reactions should be investigated further. It is likely that such studies will make important contributions to the understanding of host-parasite interactions.

Although ruminants are clinically affected by N. caninum infection, cattle generally show few clinical symptoms following the infection. Specific antibody and cell-mediated immune responses have been observed in both naturally infected cattle and those experimentally infected with N. caninum. It is important also to consider the differences in immune responses between pregnant and non-pregnant cattle, since pregnancy can modulate the immune responses against N. caninum [36]. In early pregnancy, strong Th1 immune responses against the parasite antigen at the maternal-foetal interface may induce abortion. Thus, a Th1 immune response is thought to be detrimental to pregnancy [37,38]. Th1 immune responses at the maternal-foetal interface including CD4+ cell infiltration and IFN–γ expression have been associated with tissue destruction in early or mid- gestation [39,40]. Therefore, migration of inflammatory cells at the maternal-foetal interface may trigger the N. caninum-induced abortion. Our previous study showed that recombinant NcCyp caused the CCR5-dependent migration of bovine peripheral blood mononuclear cells [13]. This result suggests that CCR5-dependent immunity may be involved in bovine abortion following N. caninum infection.

Conclusions

Our findings indicate that migration and activation of immune cells via CCR5 is required for controlling N. caninum parasites during the early phase of the infection. Our data suggest that dendritic cells and microglia play a role in CCR5-mediated protectve immunity against N. caninum. Hence, it is important to consider the contribution that the parasite-derived molecule such as NcCyp plays in CCR5-dependent host immunity.

Abbreviations

CCR5:

C-C chemokine receptor 5

CCL5:

C-C ligand 5

NK cell:

Natural killer cell

NKT cell:

Natural killer T cell

MIP-1α:

Macrophage inflammatory protein-1 alpha

MIP-1β:

Macrophage inflammatory protein-1 beta

TgCyp18:

Toxoplasma gondii cyclophilin 18

EMEM:

Eagle’s minimum essential medium

FBS:

Fetal bovine serum

UNG:

Urasil-N-glycosilase

Ct:

Cycle threshold

GAPDH:

Glyceraldehyde-3-phosphate dehydrogenase

mAb:

Monoclonal antibody

PE:

Phycoerythrin

BMDC:

Bone marrow-derived dendritic cell

GM-CSF:

Granulocyte-macrophage colony-stimulating factor

NO:

Nitric oxide

CNS:

Central nervous system

NcCyp:

Neospora caninum-derived cyclophilin

WT:

Wild-type

PEC:

Peritoneal cell

dpi:

Days post-infection

MFI:

Mean fluorescence intensity

References

  1. Dubey JP, Schares G, Ortega-Mora L: Epidemiology and control of neosporosis and Neospora caninum . Clin Microbiol Rev 2007, 20:323–367.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Dubey JP: Review of Neospora caninum and neosporosis in animals. Korean J Parasitol 2003, 41:1–16.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Nishikawa Y, Tragoolpua K, Inoue N, Makala L, Nagasawa H, Otsuka H, Mikami T: In the absence of endogenous gamma interferon, mice acutely infected with Neospora caninum succumb to a lethal immune response characterized by inactivation of peritoneal macrophages. Clin Diagn Lab Immunol 2001, 8:811–8164.

    CAS  PubMed Central  PubMed  Google Scholar 

  4. Denkers EY: From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii . FEMS Immunol Med Microbiol 2003, 39:193–203.

    Article  CAS  PubMed  Google Scholar 

  5. Denkers EY, Butcher BA, Del Rio L, Kim L: Manipulation of mitogen-activated protein kinase/nuclear factor-kappaB-signaling cascades during intracellular Toxoplasma gondii infection. Immunol Rev 2004, 201:191–205.

    Article  CAS  PubMed  Google Scholar 

  6. Dion S, Germon S, Guiton R, Ducournau C, Dimier-Poisson I: Functional activation of T cells by dendritic cells and macrophages exposed to the intracellular parasite Neospora caninum . Int J Parasitol 2011, 41:685–695.

    Article  CAS  PubMed  Google Scholar 

  7. Mueller A, Strange PG: The chemokine receptor, CCR5. Int J Biochem Cell Biol 2004, 36:35–38.

    Article  CAS  PubMed  Google Scholar 

  8. Sato N, Kuziel WA, Melby PC, Reddick RL, Kostecki V, Zhao W, Maeda N, Ahuja SK, Ahuja SS: Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR)5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice. J Immunol 1999, 163:5519–5525.

    CAS  PubMed  Google Scholar 

  9. Belnoue E, Kayibanda M, Deschemin JC, Viguier M, Mack M, Kuziel WA, Rénia L: CCR5 deficiency decreases susceptibility to experimental cerebral malaria. Blood 2003, 101:4253–4259.

    Article  CAS  PubMed  Google Scholar 

  10. Aliberti J, Reis e Sousa C, Schito M, Hieny S, Wells T, Huffnagle GB, Sher A: CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha + dendritic cells. Nat Immunol 2000, 1:83–87.

    Article  CAS  PubMed  Google Scholar 

  11. Ibrahim HM, Bannai H, Xuan X, Nishikawa Y: Toxoplasma gondii cyclophilin 18-mediated production of nitric oxide induces bradyzoite conversion in a CCR5-dependent manner. Infect Immun 2009, 77:3686–3695.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Mineo TW, Oliveira CJ, Silva DA, Oliveira LL, Abatepaulo AR, Ribeiro DP, Ferreira BR, Mineo JR, Silva JS: Neospora caninum excreted/secreted antigens trigger CC-chemokine receptor 5-dependent cell migration. Int J Parasitol 2010, 40:797–805.

    Article  CAS  PubMed  Google Scholar 

  13. Kameyama K, Nishimura M, Punsantsogvoo M, Ibrahim HM, Xuan X, Furuoka H, Nishikawa Y: Immunological characterization of Neospora caninum cyclophilin. Parasitology 2012, 139:294–301.

    Article  CAS  PubMed  Google Scholar 

  14. Reichel MP, Ellis JT: Neospora caninum – How close are we to development of an efficacious vaccine that prevents abortion in cattle. Int J Parasitol 2009, 39:1173–1187.

    Article  PubMed  Google Scholar 

  15. Hiasa J, Nishimura M, Itamoto K, Xuan X, Inokuma H, Nishikawa Y: ELISAs based on Neospora caninum dense granule protein 7 and profilin for estimating the stage of neosporosis. Clin Vaccine Immunol 2012, 19:411–417.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992, 176:1693–1702.

    Article  CAS  PubMed  Google Scholar 

  17. Rozenfeld C, Martinez R, Figueiredo RT, Bozza MT, Lima FR, Pires AL, Silva PM, Bonomo A, Lannes-Vieira J, De Souza W, Moura-Neto V: Soluble factors released by Toxoplasma gondii -infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration. Infect Immun 2003, 71:2047–2057.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Aliberti J, Valenzuela JG, Carruthers VB, Hieny S, Andersen J, Charest H, Reis e Sousa C, Fairlamb A, Ribeiro JM, Sher A: Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat Immunol 2003, 4:485–490.

    Article  CAS  PubMed  Google Scholar 

  19. Khan IA, Thomas SY, Moretto MM, Lee FS, Islam SA, Combe C, Schwartzman JD, Luster AD: CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog 2006, 2:e49.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gâtel D, Tardieux I: CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 2006, 107:309–316.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Abe C, Tanaka S, Ihara F, Nishikawa Y: Macrophage depletion prior to Neospora caninum infection results in severe neosporosis in mice. Clin Vaccine Immunol 2014, 21:1185–1188.

    Article  CAS  PubMed  Google Scholar 

  22. Nishikawa Y, Zhang H, Ibrahim HM, Yamada K, Nagasawa H, Xuan X: Roles of CD122 + cells in resistance against Neospora caninum infection in a murine model. J Vet Med Sci 2010, 72:1275–1282.

    Article  PubMed  Google Scholar 

  23. Taga T, Kishimoto T: gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997, 15:797–819.

    Article  CAS  PubMed  Google Scholar 

  24. Ambrosini E, Aloisi F: Chemokines and glial cells: a complex network in the central nervous system. Neurochem Res 2004, 29:1017–1038.

    Article  CAS  PubMed  Google Scholar 

  25. Chao CC, Anderson WR, Hu S, Gekker G, Martella A, Peterson PK: Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin Immunol Immunopathol 1993, 67:178–183.

    Article  CAS  PubMed  Google Scholar 

  26. Chao CC, Gekker G, Hu S, Peterson PK: Human microglial cell defense against Toxoplasma gondii . The role of cytokines. J Immunol 1994, 152:1246–1252.

    CAS  PubMed  Google Scholar 

  27. Suzuki Y: Host resistance in the brain against Toxoplasma gondii . J Infect Dis 2002, 185(Suppl 1):S58–65.

    Article  CAS  PubMed  Google Scholar 

  28. Gamo K, Kiryu-Seo S, Konishi H, Aoki S, Matsushima K, Wada K, Kiyama H: G-protein-coupled receptor screen reveals a role for chemokine receptor CCR5 in suppressing microglial neurotoxicity. J Neurosci 2008, 28:11980–11988.

    Article  CAS  PubMed  Google Scholar 

  29. Weber C, Weber KS, Klier C, Gu S, Wank R, Horuk R, Nelson PJ: Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T H 1-like/CD45RO + T cells. Blood 2001, 97:1144–1146.

    Article  CAS  PubMed  Google Scholar 

  30. Huffnagle GB, McNeil LK, McDonald RA, Murphy JW, Toews GB, Maeda N, Kuziel WA: Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans . J Immunol 1999, 163:4642–4646.

    CAS  PubMed  Google Scholar 

  31. Thapa M, Kuziel WA, Carr DJ: Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J Virol 2007, 81:3704–3713.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Teixeira MM, Vilela MC, Soriani FM, Rodrigues DH, Teixeira AL: Using intravital microscopy to study the role of chemokines during infection and inflammation in the central nervous system. J Neuroimmunol 2010, 224:62–65.

    Article  CAS  PubMed  Google Scholar 

  33. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM: Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 2005, 202:1087–1098.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Ibrahim HM, Xuan X, Nishikawa Y: Toxoplasma gondii cyclophilin 18 regulates the proliferation and migration of murine macrophages and spleen cells. Clin Vaccine Immunol 2010, 17:1322–1329.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Ibrahim HM, Nishimura M, Tanaka S, Awadin W, Furuoka H, Xuan X, Nishikawa Y: Overproduction of Toxoplasma gondii cyclophilin-18 regulates host cell migration and enhances parasite dissemination in a CCR5-independent manner. BMC Microbiol 2014, 14:76.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Innes EA, Andrianarivo AG, Björkman C, Williams DJ, Conrad PA: Immune responses to Neospora caninum and prospects for vaccination. Trends Parasitol 2002, 18:497–504.

    Article  CAS  PubMed  Google Scholar 

  37. Raghupathy R: Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997, 18:478–482.

    Article  CAS  PubMed  Google Scholar 

  38. Menzies FM, Henriquez FL: Immunomodulation by the Female Sex Hormones. Open Infect Dis J 2009, 3:61–72.

    Article  CAS  Google Scholar 

  39. Maley SW, Buxton D, Macaldowie CN, Anderson IE, Wright SE, Bartley PM, Esteban-Redondo I, Hamilton CM, Storset AK, Innes EA: Characterization of the immune response in the placenta of cattle experimentally infected with Neospora caninum in early gestation. J Comp Pathol 2006, 135:130–141.

    Article  CAS  PubMed  Google Scholar 

  40. Maley SW, Buxton D, Rae AG, Wright SE, Schock A, Bartley PM, Esteban-Redondo I, Swales C, Hamilton CM, Sales J, Innes EA: The pathogenesis of neosporosis in pregnant cattle: inoculation at mid-gestation. J Comp Pathol 2003, 129:186–195.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Dr. Dubey (United States Department of Agriculture, Agriculture Research Service, Livestock and Poultry Sciences Institute, Parasite Biology and Epidemiology Laboratory) for the N. caninum Nc-1 isolate. We also thank Youko Matsushita, Megumi Noda, and Yoshie Imura (National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine) for their excellent technical assistance. This research was supported by the Japan Society for the Promotion of Science through the “Funding Program for Next-Generation World-Leading Researchers (NEXT Program)”, initiated by the Council for Science and Technology Policy (2011/LS003).

Author information

Authors and Affiliations

  1. National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-cho, Obihiro, Hokkaido, 080-8555, Japan

    Chisa Abe, Sachi Tanaka, Maki Nishimura, Fumiaki Ihara, Xuenan Xuan & Yoshifumi Nishikawa

  2. Faculty of Agriculture, Shinshu University, Minami-Minowa, Kamiina, Nagano, 399-4598, Japan

    Sachi Tanaka

Authors
  1. Chisa Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sachi Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maki Nishimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fumiaki Ihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xuenan Xuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshifumi Nishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshifumi Nishikawa.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

CA, ST, MN, FI & YN performed the experiments, CA, XX & YN designed the study, CA & YN wrote the paper. All authors read and approved the final version of the manuscript.

Additional file

Additional file 1: Table S1.

List of monoclonal antibody used in this study.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abe, C., Tanaka, S., Nishimura, M. et al. Role of the chemokine receptor CCR5-dependent host defense system in Neospora caninum infections. Parasites Vectors 8, 5 (2015). https://doi.org/10.1186/s13071-014-0620-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13071-014-0620-5

Keywords

Parasites & Vectors

ISSN: 1756-3305

Contact us